[June 19, 2013] Biotronik Exhibits DX System at Premier Healthcare Alliance's Breakthroughs Conference and Exhibition Tweet Jun 19, 2013 (Close-Up Media via COMTEX) -- The Biotronik DX System, an implantable cardiac defibrillator (ICD) providing dual-chamber diagnostic capabilities with a single lead, was one of 14 medical advancements on display in front of thousands of healthcare providers and experts at the Premier healthcare alliance's 2013 Breakthroughs Conference and Exhibition. In a release, Biotronik said that it showcased during the conference's fifth annual Innovation Celebration, which took place on June 11 in San Antonio, Texas. The event recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes. Biotronik said that its DX System was selected for display by clinicians and other members of Premier, a provider-owned performance improvement alliance of more than 2,800 hospitals and nearly 100,000 other care sites, on the basis of strenuous selection criteria. These included the uniqueness of the product, its ability to have an impact on an unmet medical need and its potential to improve patient care. The DX System - comprised of the Lumax 740 VR-T DX or the recently FDA-approved Ilesto 7 VR-T DX, and Linoxsmart S DX lead - offers the benefits of both single and dual-chamber ICDs. In addition to providing a technology in the fight against heart disease, the DX System solves the controversial issue of device selection. The use of dual-chamber devices in patients without a clear indication for the use of an additional atrial lead has received a great deal of attention over the past few years. The DX System virtually eliminates this issue, representing a new paradigm in ICD therapy that fills a critical clinical need. "We're incredibly honored to be recognized at Premier's Innovation Celebration for a system that has been years in the making," said Rex Richmond, vice president of marketing and communications at Biotronik, Inc. "Since receiving FDA approval this past February, demand for the DX System has exceeded our expectations. Patients and physicians across the United States now have the benefits of a single-chamber, single-lead ICD with the full atrial diagnostic capabilities of a dual-chamber device - but with far less hardware." "Those who attend and participate in the Innovation Celebration share Premier's commitment to providing innovative, valuable products to our members that are safe, high-quality and cost-effective," said Durral R. Gilbert, president of supply chain services, Premier. "These advancements will truly benefit providers as they work to improve the health of their communities." ((Comments on this story may be sent to [email protected])) [ Back To TMCnet.com's Homepage ]